| RS2131153753 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131158061 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS2131162364 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuromuscular disease, Neuromuscular disease |
| RS2131164463 |
SPTAN1
|
Health Risk |
Likely pathogenic |
SPTAN1-related disorder, SPTAN1-related disorder |
| RS2131165749 |
TDRD7
|
Health Risk |
Pathogenic |
Cataract 36, Cataract 36 |
| RS2131167421 |
NUP188
|
Health Risk |
Likely pathogenic |
Microcephaly, Sandestig-stefanova syndrome |
| RS2131175203 |
DNM1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS2131177211 |
VPS13A
|
Health Risk |
Likely pathogenic |
— |
| RS2131179725 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131179937 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131179950 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131186551 |
NUP188
|
Health Risk |
Likely pathogenic |
Microcephaly, Sandestig-stefanova syndrome |
| RS2131192568 |
ADAMTSL2
|
Health Risk |
Likely pathogenic |
Geleophysic dysplasia 1, Geleophysic dysplasia 1 |
| RS2131192653 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2131193011 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131193680 |
VPS13A
|
Health Risk |
Pathogenic |
Ovarian serous cystadenocarcinoma, Ovarian serous cystadenocarcinoma |
| RS2131195627 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131195653 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131195691 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131207174 |
TEK
|
Health Risk |
Likely pathogenic |
— |
| RS2131207249 |
TEK
|
Health Risk |
Likely pathogenic |
— |
| RS2131215770 |
DOCK8
|
Health Risk |
Likely pathogenic |
Combined immunodeficiency due to DOCK8 deficiency, Combined immunodeficiency due to DOCK8 deficiency |
| RS2131216563 |
PLEC
|
Health Risk |
Likely pathogenic |
— |
| RS2131216928 |
GRIN1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy 101, Developmental and epileptic encephalopathy 101 |
| RS2131217643 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131227624 |
SLC20A2
|
Health Risk |
Likely pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2131227936 |
TEK
|
Health Risk |
Pathogenic |
Multiple cutaneous and mucosal venous malformations, Vascular malformation |
| RS2131228068 |
SLC20A2
|
Health Risk |
Pathogenic |
Idiopathic basal ganglia calcification 1, Idiopathic basal ganglia calcification 1 |
| RS2131228451 |
SLC20A2
|
Health Risk |
Pathogenic |
— |
| RS2131230395 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131231475 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131231500 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131235872 |
COQ4
|
Health Risk |
Likely pathogenic |
Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome, Neonatal encephalomyopathy-cardiomyopathy-respiratory distress syndrome |
| RS2131236556 |
TMEM70
|
Health Risk |
Pathogenic/Likely pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS2131236570 |
TMEM70
|
Health Risk |
Pathogenic |
Mitochondrial complex V (ATP synthase) deficiency, nuclear type 2 |
| RS2131239154 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2131239517 |
TEK
|
Health Risk |
Pathogenic |
— |
| RS2131246743 |
TEK
|
Health Risk |
Likely pathogenic |
Segmental undergrowth associated with venous malformation without capillary component, Segmental undergrowth associated with venous malformation without capillary component |
| RS2131246761 |
TEK
|
Health Risk |
Likely pathogenic |
Segmental undergrowth associated with venous malformation without capillary component, Segmental undergrowth associated with venous malformation without capillary component |
| RS2131246864 |
TEK
|
Health Risk |
Pathogenic |
— |
| RS2131249868 |
SLC27A4
|
Health Risk |
Likely pathogenic |
Lamellar ichthyosis, Lamellar ichthyosis |
| RS2131259309 |
SLC27A4
|
Health Risk |
Likely pathogenic |
— |
| RS2131265398 |
SLC27A4
|
Health Risk |
Pathogenic |
Ichthyosis prematurity syndrome, Ichthyosis prematurity syndrome |
| RS2131266023 |
TEK
|
Health Risk |
Likely pathogenic |
Glaucoma 3, primary congenital |
| RS2131266064 |
SLC27A4
|
Health Risk |
Pathogenic |
Ichthyosis prematurity syndrome, Ichthyosis prematurity syndrome |
| RS2131266202 |
ELN
|
Health Risk |
Pathogenic/Likely pathogenic |
Supravalvar aortic stenosis, Williams syndrome |
| RS2131266696 |
PLEC
|
Health Risk |
Likely pathogenic |
Epidermolysis bullosa simplex 5B, with muscular dystrophy |
| RS2131267421 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131267665 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Distal spinal muscular atrophy, Distal spinal muscular atrophy |
| RS2131267739 |
TEK
|
Health Risk |
Likely pathogenic |
Venous malformation, Venous malformation |
| RS2131267744 |
TEK
|
Health Risk |
Pathogenic |
Vascular malformation, Vascular malformation |
| RS2131267771 |
TEK
|
Health Risk |
Pathogenic/Likely pathogenic |
Segmental undergrowth associated with venous malformation without capillary component, Vascular malformation |
| RS2131269203 |
NR5A1
|
Health Risk |
Likely pathogenic |
— |
| RS2131269262 |
NR5A1
|
Health Risk |
Pathogenic |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS2131272367 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131277629 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS2131277648 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS2131277756 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY partial gonadal dysgenesis |
| RS2131279850 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2131279852 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS2131279881 |
NR5A1
|
Health Risk |
Pathogenic |
— |
| RS2131283599 |
DNM1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS2131284343 |
PLEC
|
Health Risk |
Pathogenic |
Epidermolysis bullosa simplex 5C, with pyloric atresia |
| RS2131286907 |
NR5A1
|
Health Risk |
Likely pathogenic |
Premature ovarian failure 7, Premature ovarian failure 7 |
| RS2131286914 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS2131286921 |
NR5A1
|
Health Risk |
Pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2131289685 |
NR5A1
|
Health Risk |
Pathogenic |
Disorder of sexual differentiation, 46 |
| RS2131289687 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS2131289701 |
NR5A1
|
Health Risk |
Pathogenic |
Oligosynaptic infertility, 46 |
| RS2131289726 |
NR5A1
|
Health Risk |
Pathogenic |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS2131289737 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS2131289790 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS2131289833 |
NR5A1
|
Health Risk |
Pathogenic |
Disorder of sexual differentiation, Disorder of sexual differentiation |
| RS2131289951 |
NR5A1
|
Health Risk |
Likely pathogenic |
— |
| RS2131289973 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS2131289982 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS2131290009 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY sex reversal 3 |
| RS2131290040 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY sex reversal 3 |
| RS2131291544 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131293113 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131293274 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131293320 |
VPS13A
|
Health Risk |
Pathogenic |
— |
| RS2131294861 |
SETX
|
Health Risk |
Likely pathogenic |
— |
| RS2131296288 |
SOHLH1
|
Health Risk |
Likely pathogenic |
Genetic non-acquired premature ovarian failure, Genetic non-acquired premature ovarian failure |
| RS2131297379 |
GRIN1
|
Health Risk |
Pathogenic |
— |
| RS2131297403 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131297434 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131297826 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS2131298613 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131298649 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131298697 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS2131299136 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131299235 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS2131299400 |
GRIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131299485 |
DNM1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS2131299944 |
GRIN1
|
Health Risk |
Likely pathogenic |
— |
| RS2131302722 |
GRIN1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS2131304244 |
TFR2
|
Health Risk |
Likely pathogenic |
Hereditary hemochromatosis, Hereditary hemochromatosis |
| RS2131307481 |
KRIT1
|
Health Risk |
Pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |
| RS2131307878 |
KRIT1
|
Health Risk |
Likely pathogenic |
Cerebral cavernous malformation, Cerebral cavernous malformation |